Industrials

Chrysos Corporation Limited (C79)

Chrysos Corporation provides innovative assay technology to the global mining industry. Their flagship product, PhotonAssay™, offers a rapid, safer, and more environmentally friendly alternative to traditional fire assay for analyzing gold, silver, and other minerals. The company operates a Technology-as-a-Service (TaaS) model, leasing its units to major mining companies and commercial laboratories under long-term contracts.

Market Cap

A$1.0B

Shares on Issue

N/A

Company WebsiteAI coverage updated hourlyData from ASX filings

Price Chart

Loading chart…

AI Analysis

Chrysos is in a high-growth phase, focused on deploying its PhotonAssay™ units globally. The company's performance is measured by its success in signing new long-term lease agreements, which builds its Total Contract Value (TCV) — a key forward-looking revenue indicator. Recent results have shown strong growth in both deployed units and sample volumes processed, driving recurring revenue, though the company is still investing heavily in manufacturing and global expansion, impacting short-term profitability.

The company's growth outlook is tied to the continued disruption of the conventional fire assay market. Key catalysts include securing contracts with tier-one mining houses and expanding its footprint in major mining jurisdictions like North America and Africa. Strategically, Chrysos aims to leverage its first-mover advantage and technological superiority to become the new industry standard, with potential future growth from expanding the technology's application to other commodities.

Bull Case

  • Disruptive technology with a strong value proposition in speed, safety, accuracy, and ESG benefits over traditional fire assay.
  • High-quality recurring revenue from a Technology-as-a-Service (TaaS) model with long-term contracts, providing earnings visibility.
  • Large, underpenetrated Total Addressable Market (TAM) as the global mining industry slowly transitions away from legacy assay methods.

Bear Case

  • Customer concentration risk, with a significant portion of revenue historically dependent on a few large laboratory clients.
  • Execution risk associated with scaling manufacturing, deployment, and maintenance of a complex global fleet of units.
  • Potential for future competition as the technology proves its commercial viability, or if incumbents develop their own solutions.

Recent Announcements

Chrysos Corporation 1H FY26 Results

🚨 Price Sensitive
17 Feb 2026Price Sensitive

Chrysos Corporation (C79) reported a strong first half of the financial year ending June 30, 2026, with significant revenue growth and improved profit margins.

1H FY26 Results Presentation

🚨 Price Sensitive
17 Feb 2026Price Sensitive

C79 (ASX) presented its first half fiscal year results for FY2026, revealing a strong financial performance with key metrics exceeding expectations. Investors are encouraged to review the detailed report and consider holding or increasing their positions in C79 shares

Consolidated Financial Statements Half Year 31 December 2025

17 Feb 2026Half Year Results

Appendix 4D HY26

🚨 Price Sensitive
17 Feb 2026Price Sensitive

C79 (Appendix 4D) has released its Periodic Report, which includes the latest financial statements and management's discussion for fiscal year-end Hy26. Investors are encouraged to review this comprehensive report in detail before making any investment decisions.

FAQs

What does C79 do?

Chrysos Corporation leases its proprietary PhotonAssay™ technology to mining companies and laboratories. This technology provides a much faster, safer, and more environmentally friendly way to determine the concentration of gold and other elements in geological samples compared to the traditional fire assay method.

Is C79 a good investment?

C79 offers a compelling high-growth investment case based on its disruptive technology and recurring revenue model. However, it is a relatively young company with significant execution risks in scaling its operations globally and faces risks such as customer concentration. The investment thesis depends on its ability to continue winning market share from the incumbent fire assay industry.

What drives C79's share price?

C79's share price is primarily driven by announcements of new unit lease agreements and the growth of its Total Contract Value (TCV). Other key drivers include quarterly updates on revenue growth and sample volumes, progress towards achieving positive operating cash flow, and broader industry trends towards adopting safer and more sustainable (ESG) technologies.